InvestSMART

The article you are trying to access does not exist, however, here are some articles you may be interested in.

SomnoMed Limited (ASX: SOM) - Announcements

- Current share price for SOM : $0.420

ASX company news and announcements for SomnoMed Limited (SOM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All SomnoMed Limited (SOM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than SomnoMed Limited (SOM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for SomnoMed Limited (SOM)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$92 Change in substantial holding 10 May 2024 11:47AM $0.205 $0.420 risen by 104.88%
$92 Change of Director's Interest Notice 9 May 2024 8:22AM $0.203 $0.420 risen by 107.41%
$92 Change of Director's Interest Notice 8 May 2024 5:25PM $0.203 $0.420 risen by 107.41%
$92 Change of Director's Interest Notice 8 May 2024 5:24PM $0.203 $0.420 risen by 107.41%
$92 Change of Director's Interest Notice 8 May 2024 5:23PM $0.203 $0.420 risen by 107.41%
$92 Change of Director's Interest Notice 8 May 2024 5:22PM $0.203 $0.420 risen by 107.41%
$92 Change in substantial holding 8 May 2024 1:16PM $0.200 $0.420 risen by 110%
$92 Application for quotation of securities - SOM 8 May 2024 10:16AM $0.210 $0.420 risen by 100%
$92 Completion of retail component of Entitlement Offer 3 May 2024 4:50PM $0.210 $0.420 risen by 100%
$92 Notification of cessation of securities - SOM 1 May 2024 5:46PM $0.215 $0.420 risen by 95.35%
$92 Quarterly Activities Report 29 Apr 2024 9:10AM $0.210 $0.420 risen by 100%
$92 Quarterly Cashflow Report 29 Apr 2024 9:10AM $0.210 $0.420 risen by 100%
$92 Change in substantial holding 18 Apr 2024 7:17PM $0.205 $0.420 risen by 104.88%
$92 Change in substantial shareholding from AEF 18 Apr 2024 4:04PM $0.205 $0.420 risen by 104.88%
$92 Application for quotation of securities - SOM 16 Apr 2024 8:50AM $0.215 $0.420 risen by 95.35%
$92 Dispatch of Entitlement Offer documents 16 Apr 2024 8:49AM $0.215 $0.420 risen by 95.35%
$92 Replacement Prospectus 16 Apr 2024 8:44AM $0.215 $0.420 risen by 95.35%
$92 Reinstatement to Quotation 10 Apr 2024 9:59AM $0.385 $0.420 risen by 9.09%
$92 Completion of institutional component of Entitlement Offer 10 Apr 2024 9:59AM $0.385 $0.420 risen by 9.09%
$92 Proposed issue of securities - SOM 9 Apr 2024 9:51AM $0.385 $0.420 risen by 9.09%
$92 Investor Presentation 9 Apr 2024 9:37AM $0.385 $0.420 risen by 9.09%
$92 Prospectus Entitlement Offer 9 Apr 2024 9:37AM $0.385 $0.420 risen by 9.09%
$92 Revised guidance and capital raising 9 Apr 2024 9:37AM $0.385 $0.420 risen by 9.09%
$92 Update on voluntary suspension & FY24 earnings guidance 5 Apr 2024 9:41AM $0.385 $0.420 risen by 9.09%
$92 Suspension from Quotation 2 Apr 2024 11:08AM $0.385 $0.420 risen by 9.09%

101 - 125 of 680 results

Page 5 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.